Literature DB >> 14729769

Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification.

L Galiuto.   

Abstract

Mesh：

Year:  2004        PMID： 14729769      PMCID： PMC1768057          DOI： 10.1136/hrt.2003.020800

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

1.  Resolution of refractory no-reflow with intracoronary epinephrine.

Authors:  Kimberly A Skelding; James A Goldstein; Laxmi Mehta; Mark C Pica; William W O'Neill
Journal:  Catheter Cardiovasc Interv       Date:  2002-11       Impact factor: 2.692

2.  Mechanical prevention of distal embolization during primary angioplasty: safety, feasibility, and impact on myocardial reperfusion.

Authors:  Ugo Limbruno; Andrea Micheli; Marco De Carlo; Giovanni Amoroso; Roberta Rossini; Caterina Palagi; Vitantonio Di Bello; Anna Sonia Petronio; Gabriella Fontanini; Mario Mariani
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

3.  K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.

Authors:  Satoshi Genda; Tetsuji Miura; Takayuki Miki; Yoshihiko Ichikawa; Kazuaki Shimamoto
Journal:  J Am Coll Cardiol       Date:  2002-10-02       Impact factor: 24.094

4.  Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography.

Authors:  L Galiuto; A N DeMaria; U del Balzo; K May-Newman; S F Flaim; P L Wolf; M Kirchengast; S Iliceto
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

5.  Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions.

Authors:  R F Wilson; D D Laxson; J R Lesser; C W White
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

6.  Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.

Authors:  Katsuomi Iwakura; Hiroshi Ito; Masashi Ikushima; Shigeo Kawano; Atsushi Okamura; Katsuaki Asano; Tadashi Kuroda; Koji Tanaka; Tohru Masuyama; Masatsugu Hori; Kenshi Fujii
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

7.  Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

Authors:  R N Piana; G Y Paik; M Moscucci; D J Cohen; C M Gibson; A D Kugelmass; J P Carrozza; R E Kuntz; D S Baim
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

8.  Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.

Authors:  N Ikeda; T Yasu; N Kubo; S Hashimoto; Y Tsuruya; M Fujii; M Kawakami; M Saito
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

9.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation.

Authors:  L Galiuto; A Lombardo; A Maseri; L Santoro; I Porto; D Cianflone; A G Rebuzzi; F Crea
Journal:  Heart       Date:  2003-07       Impact factor: 5.994
View more
  16 in total

Review 1.  Non-invasive imaging of microvascular damage.

Authors:  L Galiuto; L Natale; L Leccisotti; G Locorotondo; A Giordano; L Bonomo; F Crea
Journal:  J Nucl Cardiol       Date:  2009-08-25       Impact factor: 5.952

2.  Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

Authors:  Chunhong Chen; Xianghua Fu; Wei Li; Xinwei Jia; Shiru Bai; Wei Geng; Kun Xing
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

3.  Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel.

Authors:  J-L Zhao; Y-J Yang; C-J Cui; S-J You; R-L Gao
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

4.  Magnetic resonance imaging characterization of circumferential and longitudinal strain under various coronary interventions in swine.

Authors:  Mohammed Sa Suhail; Mark W Wilson; Steven W Hetts; Maythem Saeed
Journal:  World J Radiol       Date:  2013-12-28

Review 5.  CMR of microvascular obstruction and hemorrhage in myocardial infarction.

Authors:  Katherine C Wu
Journal:  J Cardiovasc Magn Reson       Date:  2012-09-29       Impact factor: 5.364

6.  Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.

Authors:  Egle Sadauskiene; Diana Zakarkaite; Ligita Ryliskyte; Jelena Celutkiene; Alfredas Rudys; Sigita Aidietiene; Aleksandras Laucevicius
Journal:  Cardiovasc Ultrasound       Date:  2011-05-28       Impact factor: 2.062

7.  Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study.

Authors:  Antonello Zoni; Peter Knoll; Tiziano Gherli
Journal:  Heart Int       Date:  2006-05-28

8.  Clinical Predictors of Incomplete ST-Segment Resolution in the Patients With Acute ST Segment Elevation Myocardial Infarction.

Authors:  So Ra Park; Young Ran Kang; Myeng Ki Seo; Min Kyeng Kang; Jong Hyen Cho; Yon Jung An; Chung Hwan Kwak; Sek Jae Hwang; Young Hun Jung; Jin Yong Hwang
Journal:  Korean Circ J       Date:  2009-08-27       Impact factor: 3.243

9.  Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention.

Authors:  Hala Mahfouz Badran; Ahmed Abdel Fatah; Ghada Soltan
Journal:  J Clin Transl Res       Date:  2020-07-08

10.  Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.

Authors:  Xiao-Cong Zeng; Xing-San Li; Hong Wen
Journal:  BMC Cardiovasc Disord       Date:  2013-06-05       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.